Kereos Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Kereos General Information

Description

Developer of molecular imaging agents and therapeutics designed to provide effective detection and treatment of cancer. The company's technology can be used as a magnetic resonance imaging (MRI) agent for tumor detection, targeted chemotherapy for solid tumors to detect cardiovascular disease, and an anti-restenotic, enabling healthcare professionals to utilize a broad range of drug compounds for any desired target in the body for the treatment of a variety of diseases.

Contact Information

Website
www.kereos.com
Formerly Known As
Eos Medical
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108-3213
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Diagnostic Equipment
Corporate Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108-3213
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kereos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 01-Mar-2023 Completed Out of Business
11. Secondary Transaction - Private 01-Oct-2021 Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC 11-Jan-2012 Completed Generating Revenue
8. Later Stage VC (Series A2) 11-May-2010 Completed Generating Revenue
7. Debt - General 26-Jun-2009 Completed Generating Revenue
6. Debt - General 01-Dec-2008 Completed Generating Revenue
5. Later Stage VC 07-Feb-2007 Completed Generating Revenue
4. Later Stage VC (Series B) 20-May-2005 $19.5M $19.9M Completed Generating Revenue
3. Grant 01-Jan-2005 $7.3M $350K Completed Generating Revenue
To view Kereos’s complete valuation and funding history, request access »

Kereos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
To view Kereos’s complete cap table history, request access »

Kereos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular imaging agents and therapeutics designed to provide effective detection and treatment of cancer.
Biotechnology
Saint Louis, MO
4 As of 2022

Frederick, MD
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kereos Competitors (16)

One of Kereos’s 16 competitors is Akonni Biosystems, a Venture Capital-Backed company based in Frederick, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akonni Biosystems Venture Capital-Backed Frederick, MD
Foundation Medicine Formerly VC-backed Boston, MA
Asuragen Formerly VC-backed Austin, TX
Illumina Formerly VC-backed San Diego, CA
Biocept Formerly VC-backed San Diego, CA
You’re viewing 5 of 16 competitors. Get the full list »

Kereos Patents

Kereos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009143454-A2 Combination antitumor therapy Inactive 22-May-2008
WO-2009143454-A3 Combination antitumor therapy Inactive 22-May-2008
WO-2009065059-A2 Super-oxide dismutase mimetics Inactive 14-Nov-2007
WO-2009065059-A9 Super-oxide dismutase mimetics Inactive 14-Nov-2007
AU-2007329793-A1 Improved linkers for anchoring targeting ligands Active 24-Oct-2006 A61K49/227
To view Kereos’s complete patent history, request access »

Kereos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kereos FAQs

  • When was Kereos founded?

    Kereos was founded in 1999.

  • Where is Kereos headquartered?

    Kereos is headquartered in Saint Louis, MO.

  • What is the size of Kereos?

    Kereos has 4 total employees.

  • What industry is Kereos in?

    Kereos’s primary industry is Biotechnology.

  • Is Kereos a private or public company?

    Kereos is a Private company.

  • What is Kereos’s current revenue?

    The current revenue for Kereos is .

  • How much funding has Kereos raised over time?

    Kereos has raised $31.6M.

  • Who are Kereos’s competitors?

    Akonni Biosystems, Foundation Medicine, Asuragen, Illumina, and Biocept are some of the 16 competitors of Kereos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process